(Q9)Sep 30, 2024 | (Q6)Jun 30, 2024 | (Q3)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q9)Sep 30, 2023 | (Q6)Jun 30, 2023 | (Q3)Mar 31, 2023 | (FY)Dec 31, 2022 | (Q9)Sep 30, 2022 | (Q6)Jun 30, 2022 | |
---|---|---|---|---|---|---|---|---|---|---|
Assets | ||||||||||
Money funds | 35.45%38.12B | 22.16%42.13B | -1.38%42.72B | -5.07%31.46B | 6.08%28.14B | 2.28%34.49B | 28.59%43.32B | 1.81%33.13B | 21.99%26.53B | 34.94%33.72B |
Loan and account receivables | ---- | ---- | ---- | ---- | ---- | ---- | ---- | -2.22%397.27B | -2.44%399.4B | -1.15%398.42B |
Transactional financial assets | 27.69%674.14B | 32.54%647.82B | 33.01%611.91B | 2,089.77%581.6B | 2,780.10%527.95B | 3,235.11%488.76B | 3,526.19%460.06B | 115.01%26.56B | 50.29%18.33B | 19.60%14.66B |
Derivative assets | -74.58%15M | -79.75%16M | -90.40%17M | -91.37%17M | -53.91%59M | -65.35%79M | -41.20%177M | -23.94%197M | -31.18%128M | 29.55%228M |
Bought sellback assets | 65.38%21.62B | -13.00%22.4B | -20.61%14.36B | -86.71%2.81B | -12.18%13.07B | 176.81%25.74B | 100.38%18.09B | 57.27%21.12B | 314.77%14.88B | -41.22%9.3B |
Other receivables (including interest and dividends) | ---- | ---- | ---- | ---- | ---- | ---- | ---- | -3.77%19.66B | 1.11%22.08B | 2.74%18.74B |
-Dividend receivable | ---- | ---- | ---- | ---- | ---- | ---- | ---- | -3.77%19.66B | 1.11%22.08B | 2.74%18.74B |
Insurance receivables | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | 12.88%44.16B | 18.21%49.01B |
Reinsurance receivables | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | -12.21%8.19B | 10.01%8.55B |
Receivable deposit for undue duty of reinsurance | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | -5.16%8.39B | -1.12%9.02B |
Receivable reserves for reinsurance outstanding claims | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | 22.24%11.69B | 28.20%10.36B |
Receivable reserves for reinsured life insurance liabilities | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | 2.41%2B | 2.89%2.03B |
Receivable reserves for reinsured long-term health insurance liabilities | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | 1.12%12.09B | 4.20%12.18B |
Policy pledge loans | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | 5.34%69.35B | 5.75%68.68B |
Fixed deposit | 4.02%170.59B | 0.97%170.47B | -22.72%150.48B | -19.08%165.5B | -24.52%163.99B | -22.68%168.84B | -5.92%194.72B | 4.07%204.52B | 5.02%217.27B | 11.08%218.35B |
Refundable capital guarantee deposits | -12.57%6.71B | -9.76%7.01B | -7.12%7.02B | -2.54%7.11B | 1.94%7.68B | 5.50%7.77B | 8.11%7.56B | -1.86%7.29B | 9.80%7.53B | 7.44%7.37B |
Financial assets available for sale | ---- | ---- | ---- | ---- | ---- | ---- | ---- | 10.80%715.09B | 6.05%653.47B | 8.36%664.76B |
Held to maturity investments | ---- | ---- | ---- | ---- | ---- | ---- | ---- | 29.72%514.25B | 30.50%519.64B | 27.44%488.8B |
Debt investment | -22.47%65.93B | -21.99%67.47B | -15.36%76.32B | --82.33B | --85.04B | --86.49B | --90.17B | ---- | ---- | ---- |
Other debt investment | 18.76%1.45T | 13.81%1.34T | 14.14%1.3T | --1.25T | --1.22T | --1.18T | --1.14T | ---- | ---- | ---- |
Other equity investment | 32.99%126.83B | 34.45%121.37B | 21.40%109.61B | --97.97B | --95.37B | --90.27B | --90.29B | ---- | ---- | ---- |
Long term equity investment | -0.91%22.75B | -5.88%23.13B | -12.51%22.97B | -10.24%23.18B | -8.58%22.96B | -2.74%24.57B | -3.47%26.26B | -4.28%25.83B | 6.18%25.12B | 11.06%25.27B |
Investment property | 6.33%11.4B | -4.73%10.38B | -4.44%10.5B | -4.78%10.67B | -4.46%10.73B | -6.28%10.89B | -3.15%10.99B | 49.08%11.2B | 47.65%11.23B | 51.49%11.62B |
Fixed assets | ---- | ---- | ---- | ---- | ---- | ---- | ---- | -0.22%17.47B | ---- | 4.17%16.54B |
Constru in process | ---- | ---- | ---- | ---- | ---- | ---- | ---- | 33.66%2.29B | ---- | -13.11%1.96B |
Intangible assets | 9.09%6.67B | 13.31%7.11B | 6.83%6.88B | 6.77%7.12B | 0.07%6.12B | 4.81%6.27B | 5.94%6.44B | 21.00%6.67B | 20.96%6.11B | 17.35%5.99B |
Goodwill | -1.09%1.36B | -1.09%1.36B | -1.09%1.36B | -1.09%1.36B | 0.00%1.37B | 0.00%1.37B | 0.00%1.37B | 0.00%1.37B | 0.00%1.37B | 1.11%1.37B |
Deferred tax assets | -9.12%6.92B | -2.35%5.37B | 4.22%7.48B | -64.01%7.08B | -0.17%7.62B | 30.60%5.5B | 81.49%7.18B | 884.03%19.66B | 274.48%7.63B | 115.45%4.21B |
Receivable contract reserve | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | 5.73%34.17B | 8.83%33.59B |
Other assets | 27.69%18.52B | 31.55%17.26B | 29.75%15.58B | 20.25%13.5B | 5.66%14.5B | -22.84%13.12B | -16.71%12.01B | -21.65%11.23B | 6.01%13.72B | 4.42%17B |
Exceptional items of assets | 19.74%43.69B | 19.10%42.1B | 23.02%41.06B | 19.63%40.09B | --36.48B | --35.35B | --33.38B | --33.51B | ---- | ---- |
Total assets | 18.71%2.68T | 15.92%2.55T | 12.92%2.44T | 13.16%2.34T | 6.56%2.26T | 4.83%2.2T | 6.73%2.16T | 6.43%2.07T | 10.65%2.12T | 10.78%2.1T |
Liabilities | ||||||||||
Derivative liabilities | -75.24%26M | -56.12%43M | 620.00%36M | 162.50%21M | 22.09%105M | 81.48%98M | 66.67%5M | 700.00%8M | --86M | --54M |
Funds from selling out and repurchasing financial assets | 45.43%142.45B | 35.15%97.79B | 6.41%91.97B | -3.21%115.82B | -16.26%97.95B | -23.33%72.36B | -1.54%86.44B | 62.94%119.67B | 27.65%116.97B | -8.33%94.37B |
Premiums received in advance | 4.70%4.85B | 11.38%5.81B | -27.19%4.76B | -4.83%17.03B | -44.78%4.63B | -37.64%5.22B | -16.10%6.53B | -28.87%17.89B | 14.11%8.39B | 2.80%8.37B |
Commission payable | 35.18%7.29B | 10.07%6.71B | 21.61%6.8B | 26.34%5.86B | 7.68%5.4B | 24.02%6.1B | 16.75%5.59B | 25.55%4.64B | 12.03%5.01B | 3.23%4.92B |
Reinsurance payables | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | -29.90%8.1B | -1.05%9.51B |
Compensation payable | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | 1.64%21.61B | 1.08%21.85B |
Policyholder dividend payable | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | 1.82%23.38B | 0.98%22.94B |
Insurer deposit investment | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | 18.11%118.87B | 18.57%117.35B |
Unearned premium reserve | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | 7.38%83.41B | 9.40%88.74B |
Outstanding claim reserve | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | 25.29%74.23B | 23.31%68.39B |
Policyholders’reserves for life insurance | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | 11.38%1.23T | 11.85%1.22T |
Long-term health insurance policyholders reserves | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | 23.58%148.22B | 24.31%143.55B |
Salaries payable | 18.17%8.48B | 4.82%6.61B | 3.65%6.68B | 7.09%9.25B | 7.01%7.17B | 6.27%6.31B | 12.23%6.44B | 16.91%8.64B | 21.04%6.7B | 19.81%5.93B |
Other payable (including interest and dividends) | ---- | ---- | ---- | ---- | ---- | ---- | ---- | -9.28%469M | -54.20%229M | -2.13%552M |
-Dividend payable | ---- | ---- | ---- | ---- | ---- | ---- | ---- | -9.28%469M | -54.20%229M | -2.13%552M |
Taxs payable | -12.80%2.82B | -12.33%3.49B | -38.17%3.73B | -31.55%3.54B | -37.47%3.23B | -21.90%3.98B | 14.46%6.03B | 24.84%5.17B | 11.73%5.17B | -4.84%5.1B |
Bonds payable | 0.00%10.19B | -34.12%10.1B | -16.94%10.12B | 2.86%10.29B | 1.96%10.19B | 53.38%15.33B | 21.85%12.18B | 0.04%10B | 0.04%10B | 0.04%10B |
Deferred tax liabilitise | 641.02%2.19B | 146.84%1.56B | -55.91%1.4B | 97.01%1.12B | -49.14%295M | -67.57%632M | 255.31%3.18B | -84.23%568M | -77.89%580M | -50.94%1.95B |
Other liabilitise | 26.95%47.32B | 24.43%46.79B | -2.40%37.98B | 10.15%37.38B | 44.92%37.27B | -15.75%37.6B | 9.91%38.91B | -17.24%33.93B | -35.11%25.72B | 26.91%44.63B |
Exceptional items of liabilities | 16.65%2.16T | 15.20%2.08T | 14.89%2T | 12.42%1.87T | 255,572.48%1.85T | 302,056.45%1.8T | 510,093.55%1.74T | 804,717.87%1.67T | 27.07%723M | 26.48%597M |
Total liabilities | 18.22%2.38T | 15.66%2.26T | 13.50%2.17T | 11.05%2.08T | 6.45%2.02T | 4.54%1.95T | 6.06%1.91T | 9.10%1.87T | 12.00%1.89T | 11.72%1.87T |
Shareholders equity | ||||||||||
Paid-in capital | 0.00%9.62B | 0.00%9.62B | 0.00%9.62B | 0.00%9.62B | 0.00%9.62B | 0.00%9.62B | 0.00%9.62B | 0.00%9.62B | 0.00%9.62B | 0.00%9.62B |
Capital reserve funds | 0.37%79.95B | 0.35%79.95B | 0.36%79.95B | 0.36%79.95B | 0.00%79.66B | 0.01%79.66B | 0.00%79.67B | 0.00%79.67B | -0.03%79.66B | 0.00%79.66B |
Surplus reserve funds | 0.00%5.11B | 0.00%5.11B | 0.00%5.11B | 0.00%5.11B | 0.00%5.11B | 0.00%5.11B | 0.00%5.11B | 0.00%5.11B | 0.00%5.11B | 0.00%5.11B |
Retained profit | 24.66%149.62B | 18.57%136.61B | 12.69%133.18B | 31.17%121.45B | 15.71%120.02B | 19.05%115.22B | 19.88%118.18B | -0.62%92.59B | 13.22%103.73B | 12.20%96.78B |
Other composite income | 162.26%3.45B | -1.23%10.48B | -65.06%4.52B | 169.01%7.99B | -67.97%1.32B | -33.29%10.61B | 44.10%12.95B | -158.92%-11.58B | -76.87%4.11B | -24.18%15.91B |
Ordinary risk reserve funds | 12.21%25.58B | 12.21%25.54B | 11.31%25.5B | 20.84%25.46B | 16.20%22.79B | 16.18%22.76B | 17.21%22.91B | 7.94%21.07B | 15.89%19.62B | 15.88%19.59B |
Shareholders equity without minority interests | 14.60%273.33B | 10.01%267.31B | 3.81%257.89B | 27.03%249.59B | 7.52%238.52B | 7.20%242.99B | 12.15%248.43B | -13.35%196.48B | 0.50%221.85B | 3.72%226.67B |
Minority interests | 352.91%26.64B | 344.58%26.35B | 202.10%18.39B | 248.76%18.12B | 6.75%5.88B | 7.28%5.93B | 8.47%6.09B | -8.28%5.2B | 2.02%5.51B | 3.54%5.52B |
Total shareholder equity | 22.74%299.97B | 17.97%293.66B | 8.55%276.27B | 32.74%267.7B | 7.50%244.4B | 7.20%248.92B | 12.06%254.52B | -13.22%201.67B | 0.54%227.36B | 3.72%232.2B |
Total liabilities and equity | 18.71%2.68T | 15.92%2.55T | 12.92%2.44T | 13.16%2.34T | 6.56%2.26T | 4.83%2.2T | 6.73%2.16T | 6.43%2.07T | 10.65%2.12T | 10.78%2.1T |
Currency Unit | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY |
Accounting Standards | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) |
Audit Opinions | -- | -- | -- | Unqualified opinion | -- | -- | -- | Unqualified opinion | -- | -- |
Auditor | -- | -- | -- | Ernst & Young Huaming Certified Public Accountants (Special General Partnership) | -- | -- | -- | Ernst & Young Huaming Certified Public Accountants (Special General Partnership) | -- | -- |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.
No Data
No Data